COSCIENS is a life science company with a diverse portfolio focused on the development of natural, plant-based active ingredients and engaged in the commercialization of pharmaceutical and diagnostic products.

COSCIENS’ natural active ingredient business leverages the Company’s proprietary manufacturing and extraction technologies to develop Avenanthramides and Beta Glucan active ingredients currently used in leading skincare brands worldwide. COSCIENS’ lead pharmaceutical product Macimorelin (Macrilen; Ghryvelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).

Mission/Vision:

Reinventing the nature of science

At COSCIENS we develop high performance active ingredients, therapies and technology to improve global heath and wellness.

United as ONE COSCIENS, we combine the simplicity of nature with the power of science, delivering more: more care, more healing and more well-being to the world.